Trial Profile
Pharmacodynamics, pharmacokinetics and tolerability of velcalcetide in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2014
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Amgen; KAI Pharmaceuticals
- 04 Jan 2014 New trial record
- 13 Nov 2013 Results published in Nephrology Dialysis Transplantation.